Candel Therapeutics Competitors and Similar CompaniesClear all
Candel Therapeutics's competitors and similar companies include ESSA Pharma and Oncopeptides.
 Candel Therapeutics Candel Therapeutics (formerly known as Advantagene) is a biopharmaceutical company developing cancer immunotherapies. |  ESSA Pharma ESSA Pharma is a pharmaceutical company focused on developing therapies for the treatment of prostate cancer. | ||
Founding Date | Founding Date 1999 | Founding Date 2009 | Founding Date 2000 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Needham, US HQ | Locations Vancouver, CA HQ Houston, US South San Francisco, US | Locations Stockholm, SE HQ Stockholm, SE Los Altos, US Mountain View, US Waltham, US |
Employees | Employees 50 | Employees 35 | Employees 80 |
Valuation ($) | Valuation ($) 176.8 m | Valuation ($) 240 m | Valuation ($) 42.4 m |
Financial | |||
Net income | Net income ($38.2m) (FY, 2025) | Net income ($28.5m) (FY, 2024) | Net income (kr249.6m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 64.6m | Total funding raised $ 74.1m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
ESSA Pharma
HQ
Vancouver, CA
Employees
35
ESSA Pharma is a pharmaceutical company focused on developing therapies for the treatment of prostate cancer.
View company
Oncopeptides
HQ
Stockholm, SE
Employees
80
Oncopeptides is a clinical development pharmaceutical company.
View company